Alzheimer's Disease Anti-Inflammatory Prevention Trial
How to edit trial information: Log in, click on the word [edit] to the right of the section you would like to edit, type in the appropriate information, click save page at the bottom when you are done. The template is the minimum elements required by the World Health Organization. You can add additional sections. More help to add a trial here.
Complete Title of Study
Alzheimer's Disease Anti-Inflammatory Prevention Trial
Study Acronym (The trial's abbreviation if there is one)
(ADAPT)
Principal Investigator, Co-investigators, and Collaborating Institutions
Principal Investigator: John C Breitner, MD, MPH
Sponsors and Collaborators: National Institute on Aging (NIA)and Department of Veterans Affairs
Institutions:University of Washington and Johns Hopkins University
Overview of Trial
None reported
Disease State(s) Studied (e.g. acute MI, breast cancer, etc.)
None reported
Study Phase (e.g. Phase I,II,III,IV) Study Phases are defined here
None reported
Study Design (e.g. multicenter, randomized, double blind, placebo controlled)
None reported
Study Arms and How They Were Treated (Intervention) (Explanation here)
None reported
Primary Pre-Specified Endpoint
None reported
Secondary Endpoints
None reported
Inclusion Criteria
None reported
Exclusion Criteria
None reported
Outcome: Primary endpoint (Report both relative risk reduction and absolute risk reduction as well as number needed to treat if available)
None reported
Outcome: Secondary endpoint (Report both relative risk reduction and absolute risk reduction as well as number needed to treat if available)
None reported
Outcome: Exploratory endpoints (Report both relative risk reduction and absolute risk reduction as well as number needed to treat if available)
None reported
Outcome: Safety endpoints (Report both relative risk and absolute risk as well as number needed to harm if available)
None reported
Conclusions of the Investigators (Quote the investigators conclusions here)
None reported
Commentary, Discussion and Limitations of the Trial (Anyone can add comments)
None reported
Slides
None reported
Video Commentary
None reported
References (How to insert a reference)
None reported
External sites for further information (How to insert links)
None reported
Detailed information about the trial
Ages
__ years to ___ years
Gender (Indicate whether men, women or both were enrolled)
None reported
Accepts Healthy Volunteers (Answer yes or no)
None reported
Enrollment Period (Study start and end date)
None reported
Recruitment Status (explanation)
None reported
Enrollment (Total number of patients enrolled)
None reported
Study Sponsor (e.g. Investigator initiated or company name)
None reported (this may not have yet been ascertained)
Source of Data (Where is this data on this page coming from: publication, principal investigator, or co-investigator)
None reported
The content of the clinical trial wiki consists of fields that have been suggested by the World Health Organization and wwww.clinicaltrials.gov.